1. Home
  2. HRMY vs NEXT Comparison

HRMY vs NEXT Comparison

Compare HRMY & NEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$28.56

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo NextDecade Corporation

NEXT

NextDecade Corporation

HOLD

Current Price

$5.49

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
NEXT
Founded
2017
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
HRMY
NEXT
Price
$28.56
$5.49
Analyst Decision
Buy
Hold
Analyst Count
10
2
Target Price
$46.70
$7.50
AVG Volume (30 Days)
1.1M
2.6M
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$18.83
N/A
Revenue Next Year
$12.69
N/A
P/E Ratio
$10.70
N/A
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$4.75
52 Week High
$40.87
$12.12

Technical Indicators

Market Signals
Indicator
HRMY
NEXT
Relative Strength Index (RSI) 31.12 53.32
Support Level $26.36 $4.85
Resistance Level $37.98 $5.60
Average True Range (ATR) 1.89 0.34
MACD -0.55 0.02
Stochastic Oscillator 21.93 32.00

Price Performance

Historical Comparison
HRMY
NEXT

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

Share on Social Networks: